TGF-β1 inhibits the growth and metastasis of tongue squamous carcinoma cells through Smad4

Gene

Volumn 485, Issue 2, 2011, Pages 160-166

  Wang, Xiumei ^a   Sun, Wenjing ^b   Zhang, Chengren ^a   Ji, Guohua ^b   Ge, Yana ^a   Xu, Ye ^a   Zhao, Yuzhen ^b  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Metastasis; Signaling pathway; Smad4; TGF ; Tongue squamous cell carcinoma

Indexed keywords

GELATINASE A; PROTEIN P21; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOMA CELL; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; VECTOR CONTROL;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; CELL PROLIFERATION; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; MATRIX METALLOPROTEINASE 2; MICROSCOPY, ELECTRON, TRANSMISSION; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TONGUE NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 80052030354     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.06.023     Document Type: Article

References (40)

1. Bardeesy N., et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev. 2006, 20:3130-3146.
2. Bierie B., Moses H.L. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat. Rev. Cancer 2006, 6:506-520.
3. Blobe G.C., Schiemann W.P., Lodish H.F. Role of transforming growth factor beta in human disease. N. Engl. J. Med. 2000, 342:1350-1358.
4. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 2001, 11:S27-S31.
5. Chopin V., Toillon R.A., Jouy N., Le Bourhis X. P21(WAF1/CIP1) is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells. Oncogene 2004, 23:21-29.
6. de Caestecker M.P., Piek E., Roberts A.B. Role of transforming growth factor-beta signaling in cancer. J. Natl. Cancer Inst. 2000, 92:1388-1402.
7. Derynck R., Akhurst R.J., Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 2001, 29:117-129.
8. Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003, 425:577-584.
9. Duda D.G., et al. Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells. Oncogene 2003, 22:6857-6864.
10. Ellenrieder V., Hendler S.F., Ruhland C., Boeck W., Adler G., Gress T.M. TGF-beta-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system. Int. J. Cancer 2001, 93:204-211.
11. Fukuchi M., et al. Decreased Smad4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal squamous cell carcinoma. Cancer 2002, 95:737-743.
12. Gartel A.L., Tyner A.L. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol. Cancer Ther. 2002, 1:639-649.
13. Gordon K.J., Blobe G.C. Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim. Biophys. Acta 2008, 1782:197-228.
14. Hague A., Bracey T.S., Hicks D.J., Reed J.C., Paraskeva C. Decreased levels of p26-Bcl-2, but not p30 phosphorylated Bcl-2, precede TGFbeta1-induced apoptosis in colorectal adenoma cells. Carcinogenesis 1998, 19:1691-1695.
15. Hahn S.A., et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996, 271:350-353.
16. Ijichi H., et al. Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells. Biochem. Biophys. Res. Commun. 2001, 289:350-357.
17. Ikushima H., Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat. Rev. Cancer 2010, 10:415-424.
18. Kang Y., et al. Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13909-13914.
19. Kretzschmar M., Massague J. SMADs: mediators and regulators of TGF-beta signaling. Curr. Opin. Genet. Dev. 1998, 8:103-111.
20. Leivonen S.K., Ala-Aho R., Koli K., Grenman R., Peltonen J., Kahari V.M. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells. Oncogene 2006, 25:2588-2600.
21. Liu Z.M., Chen G.G., Ng E.K., Leung W.K., Sung J.J., Chung S.C. Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells. Oncogene 2004, 23:503-513.
22. Maehara Y., et al. Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma. J. Clin. Oncol. 1999, 17:607-614.
23. Martinez L.A., et al. p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells. Carcinogenesis 2002, 23:1289-1296.
24. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 1998, 67:753-791.
25. Massague J., Seoane J., Wotton D. Smad transcription factors. Genes Dev. 2005, 19:2783-2810.
26. Mehra A., Wrana J.L. TGF-beta and the Smad signal transduction pathway. Biochem. Cell Biol. 2002, 80:605-622.
27. Muraoka R.S., et al. Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. J. Clin. Invest. 2002, 109:1551-1559.
28. Penuelas S., et al. TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 2009, 15:315-327.
29. Picon A., Gold L.I., Wang J., Cohen A., Friedman E. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1. Cancer Epidemiol. Biomarkers Prev. 1998, 7:497-504.
30. Roberts A.B. Molecular and cell biology of TGF-beta. Miner. Electrolyte Metab. 1998, 24:111-119.
31. Santibanez J.F., Quintanilla M., Martinez J. TGF-beta(1) and Smad4 overexpression induce a less invasive phenotype in highly invasive spindle carcinoma cells. FEBS Lett. 2002, 520:171-176.
32. Schwarte-Waldhoff I., et al. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:9624-9629.
33. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
34. Subramanian G., et al. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. Cancer Res. 2004, 64:5200-5211.
35. Tang B., et al. TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J. Clin. Invest. 2003, 112:1116-1124.
36. Thiagalingam S., et al. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat. Genet. 1996, 13:343-346.
37. Vidal A., Koff A. Cell-cycle inhibitors: three families united by a common cause. Gene 2000, 247:1-15.
38. Wimmel A., Wiedenmann B., Rosewicz S. Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells. Gut 2003, 52:1308-1316.
39. Yang H.L., Pan J.X., Sun L., Yeung S.C. p21 Waf-1 (Cip-1) enhances apoptosis induced by manumycin and paclitaxel in anaplastic thyroid cancer cells. J. Clin. Endocrinol. Metab. 2003, 88:763-772.
40. Yatsuoka T., et al. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma. Am. J. Gastroenterol. 2000, 95:2080-2085.